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ABSTRACT 
 
 
Malnutrition and diarrhoea are major causes of childhood morbidity and mortality in 
the developing world.  Lactose malabsorption has been associated with diarrhoea in 
malnourished children, but they are often managed with lactose containing feeds. 
This study quantified the prevalence of lactose malabsorption in children with severe 
acute malnutrition (SAM) and diarrhoea admitted to an urban South African hospital. 
Sixty-three Children with SAM and diarrhoea were included in the study and had their 
stool tested for reducing substances using the Benedict’s test. Fifty-nine percent had 
stool positive for reducing substances (≥0.5g%). After multivariate analysis, age of  
<12 months was the only factor found to significantly predict positive reducing 
substances (LR 4, p=0.046). Death was 4 times more likely in children with positive 
reducing substances (p=0.035).  The role of lactose free feeds in children with SAM 
and diarrhoea has not been adequately explored. 
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1.0 INTRODUCTION 
Malnutrition is a major contributor to the global burden of under-five disease and mortality (1).  
Wasting and severe wasting, defined as weight-for-height less than -2 and -3 standard deviations 
of the World Health Organization (WHO) Child Growth Standards, respectively, reflect acute 
malnutrition and are responsive to fluctuations in health and environment such as infections and 
changes in food security (1). As of 20 September 2013,  joint global estimates by WHO, The United 
Nations Children’s Fund (UNICEF) and the World Bank were that 17 million children under five are 
severely wasted, with an estimated prevalence of just less than 3%. Approximately 71% of all 
severely wasted children live in Asia and 28% in Africa. In Sub-Saharan Africa, the prevalence of 
severe wasting was estimated to be 9%. In South Africa, the most recent estimate of the 
prevalence of wasting in children under five years old was 4.7% in 2008 (1). 
 
Severe acute malnutrition (SAM) is defined in table 1.1 below. Any one of the three criteria in the 
table is required to diagnose SAM (2). 
 
Table 1.1: Diagnostic criteria for SAM in children aged 6–60 months (2) 
Indicator Measure Cut-off 
 
Severe wasting 
 
Weight-for-height * < -3 SD 
Severe wasting Mid Upper Arm 
Circumference (MUAC)  
< 115 mm 
Bilateral oedema 
 
Clinical sign  
*Based on WHO Standards (www.who.int/childgrowth/standards)  
 
Diarrhoea is a major cause of mortality in children with SAM (3-6). A Zambian study involving 
children with SAM found that the risk of dying was two-and-a-half times greater in those with 
diarrhoea (95% CI 1.50-4.09, p < 0.001) (3). A Kenyan study involving 1206 children hospitalised 
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with SAM and managed according to WHO guidelines found 21% mortality in those with diarrhoea 
on admission, and 12% in those without (p <0.001) (4). It is therefore important to understand the 
factors contributing to diarrhoea in SAM and to optimise management in order to improve the 
prognosis of children with SAM and diarrhoea. 
 
The association between malnutrition and lactose malabsorption (generally reflected as stool 
reducing substances greater than 0.5%) is well described (3-8). However, the recommended 
feeding formulas widely used in the management of malnutrition (such as F75), contain lactose 
(9). Their use in the setting of malnutrition with diarrhoea could be delaying recovery (5). 
 
The aim of this study is to assess the prevalence of lactose malabsorption in children with 
diarrhoea and SAM between six months and five years of age at Rahima Moosa Mother and Child 
Hospital, Johannesburg, South Africa. 
 
The primary objective of the study is to identify the presence or absence of reducing substances, 
as measured by Benedict’s test, in the stool water of children with diarrhoea and SAM. The 
secondary objective of the study is to identify the risk factors associated with the presence of 
reducing substances, as measured by Benedict’s test, in the stool water of children with diarrhoea 
and SAM. 
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2.0 LITERATURE REVIEW 
2.1 Impact of malnutrition on children with diarrhoea 
Diarrhoea as a complication of malnutrition has been substantially researched. Research has left 
no doubt as to the poor outcomes in children with severe malnutrition complicated by diarrhoea.  
The following paragraphs summarise relevant studies on diarrhoea and malnutrition. 
 
A descriptive, prospective study involving 355 children under six years of age in Colombia 
admitted with SAM or moderate acute malnutrition found that diarrhoea was the most common 
complication on admission (68.4%) (10).  
 
The presence of malnutrition increases the risk of mortality in children with diarrhoea. A large 
longitudinal study in the Philippines evaluated the effect of malnutrition on the risk of diarrhoeal 
mortality in children under two years old (11). This is one of the first longitudinal studies that 
estimates the cause-specific risk of mortality in malnourished children.  It found that malnutrition 
was associated with an increased risk of diarrhoeal mortality in all children under two years old, 
especially in children six to 11 months old; in this period, the relative risk for diarrhoeal mortality 
doubled for each one-unit decrease in weight-for-age Z score. The attributable risk of malnutrition 
for diarrhoeal mortality rose significantly from 11.5% in children zero to five months old to 37.7% 
in children six to 11 months old and 36% in children 12 – 23 months old. The authors speculated 
that the increased use of weaning foods at around six months of age put children at increased risk 
of diarrhoeal disease (11). 
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In a large cohort study in Sudan, involving 28 000 children with diarrhoea, a clear inverse 
relationship was found between weight-for-height Z-score and mortality (12). A relative risk of 
death of 1.4 (95%CI: 0.7-2.5) was found in children whose weight-for-height Z-score was minus 
one to minus two. The relative risk of death increased to 3.5 (95%CI: 1.8 – 6.6) when the Z-score 
decreased to minus two to minus three. A further increase to 26.5 (95%CI: 13.4 – 52.3) and 24.3 
(95%CI: 9.1-64, 8) was found when the Z-score decreased to minus three to minus four and less 
than minus four respectively (12).   
 
A longitudinal study in Bangladesh found that the strongest predictor of the duration of diarrhoea 
was the nutritional status of the child: the worse the nutritional status, the longer the duration of 
diarrhoea (13).  
 
A large Kenyan study found that bacteraemia, hyponatraemia, low mid-upper arm circumference, 
hypoxia, hypokalaemia and oedema were associated with mortality in children with SAM and 
diarrhoea; and that in Human Immunodeficiency Virus (HIV) infected children, diarrhoea is more 
frequent, but the risk of death is not increased compared to HIV uninfected children with SAM 
and diarrhoea (4).  
 
Despite both malnutrition and diarrhoea being common diseases in South Africa, there have been 
no studies that specifically assess the impact of malnutrition on children with diarrhoea in a South 
African setting.   
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2.2 Aetiological factors of diarrhoea in children with malnutrition 
There are many proposed causal factors for diarrhoea in malnourished children.  
 
2.2.1 Impaired immunity  
Several studies have shown that malnutrition is a major cause of secondary immune deficiency by 
impairment of cell mediated immunity and secretory immunoglobulin A (sIgA) production (14, 
15). Secretory IgA, secreted by B-lymphocytes of the Peyers patches, mediates the process of 
pathogenic antigen presentation in the gut and prevents invasion of the mucosa by neutralising 
pathogens. With decreased levels of sIgA, malnourished children are more susceptible to 
infectious diarrhoea (14, 15). Malnutrition can also cause increased lamina propria macrophages, 
lymphocytes and proinflammatory cytokine production in the gut mucosa which has been shown 
to increase gut permeability as indicated by the lactulose: mannitol absorption test (14, 15).  
 
2.2.2 Food-antigen sensitisation 
Cow’s milk protein sensitisation could be part of a post-enteritis enteropathy that plays a role in 
prolonged diarrhoea, following an episode of acute gastroenteritis (16). Cow’s milk sensitive 
enteropathy is thought to occur with or without the occurrence of lactase deficiency and is due to 
sensitisation of the damaged small intestine mucosa to milk proteins during an episode of 
gastroenteritis. This allergy can cause prolonged diarrhoea and growth failure.  It is thought to 
occur because of a combination of increased entry of antigens by passive diffusion through 
damaged mucosa coupled with thinning of the mucosa and decreased IgA in the lamina propria of 
the intestinal mucosa  (16). 
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2.2.3 Decreased intestinal villous height 
The small intestine is a metabolically demanding organ.  It accounts for 17-25% of the total body 
oxygen consumption.  It is therefore very sensitive to protein/calorie malnutrition (17). Lower 
intestinal villus heights are seen in animals that have protein/calorie malnutrition following 
decreased enterocyte turnover and reduced cell migration along the crypt-villous axis. This results 
in lower surface area and decreased mucosal mass (17).  Although it would seem logical that 
decreased surface area and mucosal mass would result in decreased nutrient absorption, nutrient 
absorption is a result of a complex interaction of hormonal signals, fluidity, composition and 
electrochemical gradient of the gut mucosa, transporter gene expression, turnover and type of 
transporters synthesised, luminal content and luminal signalling.  In malnutrition, there are 
various protective mechanisms that increase the absorption of essential micro- and 
macronutrients and result in an increased fractional absorption per gram of mucosal mass. This is 
an adaptive mechanism that decreases the metabolic demand of the small intestine, to allow 
more of the diminished nutrient stores to be delivered to the organs that are essential for 
survival, while still enhancing the absorptive function to partially compensate for the loss of 
mucosal mass. There is, however, still a decreased overall capacity for nutrient absorption 
because the reduction in mucosal mass outweighs its ability to increase absorption rates (17).  
 
2.2.4 Decreased disaccharidases 
A result of the villous atrophy seen in malnutrition, is decreased disaccharidases (including 
lactase) at the brush border of the small intestine; a secondary lactase deficiency. Thus, 
carbohydrate absorption is reduced before that of fat or protein (18). Some of these unabsorbed 
carbohydrates are metabolised to organic acids by colonic bacteria, and can then be absorbed 
across the colonic mucosa.  Carbohydrates that have not been metabolised by colonic bacteria 
and organic acids that are not absorbed by the colonic mucosa will remain in the colonic lumen 
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and exert an osmotic effect resulting in diarrhoea.   Carbohydrate malabsorption can therefore 
cause osmotic diarrhoea that can result in severe dehydration, acidosis and shock (19).  
Decreased disaccharidases is the causal factor that forms the basis of this study.  
 
2.3. Lactose malabsorption in children with SAM and diarrhoea 
Lactase is found at the tip of the brush border and is therefore the first disaccharidase to be 
affected by mucosal damage  (20). Lactase is also present in lower concentrations than the other 
brush border disaccharidases and is the last to recover from mucosal damage. It is therefore the 
most important type of secondary disaccharidase deficiency (21,22) and most relevant in the 
setting of malnutrition related villous atrophy. Sucrase deficiency may occur with lactase 
deficiency as part of a secondary disaccharidase deficiency, but does not occur as an isolated 
deficiency  (23). A deficiency in lactase will result in lactose malabsorption, also known as lactose 
intolerance. Lactose intolerance specifically implies the presence of symptoms related to lactose 
malabsorption such as diarrhoea, bloating, flatulence, abdominal cramping  (20).  
 
A Ugandan study investigated 196 severely malnourished children with diarrhoea.  Lactose 
malabsorption was detected by stool-reducing substances and stool acidity in 25.5%  (24) . They 
identified young age, kwashiorkor, peri-anal skin erosion, high mean stool frequency and recent 
or persistent diarrhoea as associated with lactose malabsorption.  HIV infection was not 
significantly associated with lactose malabsorption in this study, however, lactose malabsorption 
is commonly found in HIV-infected Southern African children (5).  
 
Across the globe, the management of malnutrition is not entirely evidence-based and 
predominantly derived from expert opinion (5). The principles of malnutrition management have 
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been reviewed and updated based on best available evidence. However, WHO ‘10 steps’ advocate 
the use of a lactose-containing formula (9). 
 
In many settings in Southern Africa, the mortality rate for children with SAM managed in hospital 
settings remains above 20% (5). This contrasts with the claim that implementation of WHO 
guidelines for the treatment of malnutrition can result in a mortality of less than 5 % (5). Mortality 
is highest in areas with least access to antibiotics, nutritional supplements, good nursing care and 
feeding regimens (6). Malnutrition complicates many other common medical conditions in 
Southern African children and contributes to their mortality (7). HIV and Tuberculosis (TB) co-
infection also complicate the management of malnutrition, but there is insufficient evidence to 
improve guidelines on the management of malnutrition in these clinical scenarios (5).  
 
In children with SAM, physiologic adaptations occur to enable the child to survive ‘starvation’.  In 
the absence of sufficient dietary macronutrient supply, catabolism of fat and protein stores 
ensues.  This provides glucose and ketones for energy but also causes wasting and organ 
dysfunction, including decreased intestinal absorptive function, particularly of lactose (5), despite 
the compensatory mechanism described in 2.2.3 above. 
 
2.4 Environmental enteropathy 
Environmental enteropathy (also known as tropical enteropathy) is a subclinical condition 
resulting from repeated faecal oral contamination that is not yet fully understood (25).  Chronic 
inflammation of the small intestine results in increased intestinal permeability, altered gut 
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immunity, blunting of the intestinal villus and malabsorption.  It causes poor growth, oral vaccine 
failure and malnutrition that is poorly responsive to nutritional therapy. It occurs among people 
living in areas with poor sanitation and inadequate hygiene (25). Decreased villous height, 
increased crypt depth, lymphocytic infiltration of the lamina propria and increased intraepithelial 
lymphocytes on biopsy as well as carbohydrate malabsorption have been associated with this 
phenomenon. Information gained from immigrants have suggested that the aetiology is most 
likely to be environmental, whereby constant exposure to faecally contaminated food and water 
results in repeated gastroenteritis and a perpetuated state of inflammation resulting in mucosal 
damage (25). This condition is closely related to malnutrition and the pathological processes of 
environmental enteropathy and malnutrition complicated by diarrhoea are likely to overlap to a 
large degree.  
2.5 Testing for lactose malabsorption in children 
Evidence for lactose malabsorption can be detected by a Clinitest®, or by the use of Benedict’s 
solution, both of which are inexpensive, bedside investigations  (26). The Clinitest ® dates back to 
1964 when Kerry and Anderson investigated its use to determine the carbohydrate content of 
stools  (27).  Clinitest® tablets are no longer being manufactured by Bayer Health Care due to lack 
of demand (28), but the Clinitest® is based on the principles of the Benedict’s test, which uses 
Benedict’s solution to detect reducing substances in a sample.  
 
Benedict’s solution contains copper (II) sulphate, sodium carbonate and sodium citrate. The blue 
copper (II) ions (present in the copper (II) sulphate) are reduced by the presence of reducing 
substances (e.g. glucose, lactose, fructose, galactose or pentose), and an external source of heat, 
to copper (I) ions, which are red in colour.  When testing stool water, the higher the concentration 
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of reducing substances in the stool water, the greater the number of copper (II) ions that will be 
reduced, corresponding to a greater colour change in the solution.   The concentration of reducing 
substances in stools is therefore demonstrated by the colour that is produced, which is compared 
to a standardised reference chart (appendix A) to estimate the percentage of reducing substances 
present in the sample (27).  Reducing substances are usually found in small quantities in the stool 
of children, but a level of more than 0.5% is considered significantly above the normal range and 
indicative of carbohydrate malabsorption (27).  Benedict’s test has been shown to be an efficient 
test to predict osmotic diarrhoea  (23,26,27). Benedict’s test does not differentiate which form of 
carbohydrate is present in the stool water. Stool chromatography is needed to identify exactly 
which carbohydrates are present in stool, but this test is cumbersome and expensive.  As 
discussed in section 2.3 above, in secondary disaccharidase deficiency, lactase is the most 
important enzyme affected, other disaccharidases are only affected in combination with lactase 
(23) and therefore the Benedict’s test or Clinitest® is a suitable proxy for the detection of lactase 
malabsorption in secondary disaccharidase deficiency.  
 
The performance of these tests in the presence of malnutrition and diarrhoea is not required 
when following WHO guidelines on the Management of malnutrition and diarrhoea (it is not 
mentioned in the WHO manual (9)) and it is seldom performed in the clinical setting.  Lactose 
malabsorption would be detected earlier if the test were routinely performed on malnourished 
children with diarrhoea.  
 
The use of a Clinitest® tablet or Benedict’s Solution avoids sending a stool specimen to the 
laboratory, which frequently results in false negative results due to the action of stool bacteria on 
reducing sugars (5). The hydrogen breath test is currently the gold standard for the detection of 
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lactose malabsorption  (24).  This test is however expensive and laborious. It also requires that the 
patient fasts and is then given a lactose ‘load’.  This procedure could be potentially harmful in 
malnourished children and therefore the hydrogen breath test is not appropriate in the routine 
clinical management of SAM and was not used in this study. 
 
2.6 Current management of children with diarrhoea and SAM 
The recommended feeding formulas widely used in the management of diarrhoea in children with 
malnutrition contain lactose. The WHO guidelines on the management of SAM recommend the 
use of F75 (which contains lactose) and do not distinguish between dietary management of 
children with and without diarrhoea (9). 
Many sites do not use F75 or F100. Lack of availability of premixed F75 and F100, and problems 
with mixing the formula as per the WHO manual (e.g. sterility and separation of oil and water in 
the formula) are the main reasons given. Many of these sites are using commercial starter 
formulas that have high lactose contents (29). 
There have been many studies on the nutritional management of severe malnutrition.   
A study in South Africa in 1965 on children with malnutrition and diarrhoea found that while on a 
milk-containing diet, 85% of the participants had sugars (lactose, galactose and glucose) 
demonstrated on stool chromatography.  When all the carbohydrates were removed from the 
diet, there was an improvement in diarrhoea.  The researchers went on to demonstrate that the 
defect was mainly in disaccharide absorption (especially lactose) rather than monosaccharide 
absorption  (30). This was a small study that used technical outcomes, such as stool weight and 
stool lactic acid. There were no clinical outcomes measured, such as improved weight gain and 
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decreased mortality that could be used to determine the clinical effectiveness of a carbohydrate 
free feed in these children.  
A Guatemalan study in 1984 compared the use of intact cow’s milk based formula, to a lactose 
free cow’s milk based formula (added β-galactosidase converted more than 90% of lactose to its 
monosaccharide) in the management of severe protein-energy malnutrition in 20 children  
(31,32).  It was concluded that the use of intact milk based feeds are not contraindicated in 
children with malnutrition. In this Guatemalan study, the authors did not specifically look at 
children with diarrhoea and the incidence of lactose malabsorption (18%) was lower than what 
has been found in other studies.  No large studies have directly compared cow’s milk based 
formulas that are lactose free, with intact milk based formulas in children with malnutrition, 
diarrhoea and lactose malabsorption.  
 
A South African study in 1989 compared the use of a soya based formula to that of a standard 
lactose containing cow’s milk formula (20 children in each group) in the management of children 
with oedematous malnutrition and found no disadvantages to the use of the soya formula.  They 
also did not find significant advantages to its use, but none of the children in their study had 
lactose malabsorption (33). Lactose free formulas that are cow’s milk based, not soya based are 
now available commercially.  These formulas may be a more relevant comparison to lactose 
containing cow’s milk formula than soya based formula.  
 
Many studies have found cereal-based diets to be associated with acceptable outcomes in the 
management of children with malnutrition (34-36). However, a Malawian study in 1997 compared 
the use of a maize-soya-egg based feed to a standard milk feed in the management of children 
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with malnutrition in 100 participants and found milk was superior, although they still 
recommended low lactose milk feed (37). 
 
A randomised control trial (RCT) done in 2002, in an Australian aboriginal population of 
malnourished children with diarrhoea, compared the use of a low-osmolality lactose-free formula 
(De-Lact), a lactose-free formula (O-Lac) and a partially hydrolysed formula (Alfaré)  (38). It 
concluded low osmolality milk was associated with better outcome and the authors of that trial 
suggested that lowering the osmolality of F75 and F100 could improve outcomes in children with 
diarrhoea and SAM  (38). It also found that the partially hydrolysed formula was associated with 
less improvement in mucosal recovery, suggesting that cow’s milk protein sensitisation was not 
contributing to greater diarrhoeal severity or enteropathy in this population. There has not been 
enough research done, in line with this RCT, specifically on the nutritional management of 
malnutrition in the face of diarrhoea and more specifically, when lactose malabsorption has been 
demonstrated. Although it is recognised as an important factor, the impact of osmolality lies 
beyond the scope of this study. The osmolality and lactose content of commonly used formulas 
are represented in table 2.1.  
 
 
 
 
 
 
  14 
Table 2.1: Lactose and osmolality content of commonly used formulas 
Formula  Osmolality (mOsm/L) Lactose Content (g/L) 
Fresh Cow’s Milk 260 48 
Breastmilk  273 74 
Nan 1 275 80 
Nan 2 Not available  56 
Infacare 1 Not available 60 
Infacare 2 Not available 80 
F 75 333 13 
F100 419 42 
 
 
Contrary to the Australian study mentioned above, a Zambian study done in 2002 hypothesised 
that food-antigen sensitisation may have a role to play in persistent diarrhoea in children with 
malnutrition and found that the use of an amino-acid based elemental feed resulted in better 
outcomes than cow’s milk or soya based feeds (39). This study did not use the comparison of a 
low-lactose or low osmolality cow’s milk based feed which could account for the difference in 
findings between this study and the Australian in terms of the suitability of elemental feeds in 
children with diarrhoea and the relevance of food-antigen sensitisation.  
 
A systematic review, of the management of malnutrition in developing countries was published in 
2012. All three RCTs  included,  that investigated the impact of diet on outcome in children with 
persistent diarrhoea and malnutrition, concluded that there was no significant difference in 
outcome between the diets (soya based versus diluted milk based feed, soya based versus chicken 
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or milk based feed, elemental versus skimmed-milk/soya based feed) (40). The overall 
methodological quality of two of the three studies in this systematic review was considered to be 
‘weak’ by the authors of the systematic review and all three were judged to be subject to bias in a 
number of areas, leaving the question of optimal nutritional management in children with 
diarrhoea and malnutrition unanswered.  
 
Although there have been many studies on the subject of nutritional management of children 
with severe malnutrition, most of these studies were small and compared cow’s milk based 
formula to soya based formula (representing a lactose free formula). Soya is source of protein 
that is known to be inferior to cow’s milk protein (41).  It has lower methionine content and high 
levels of phytate, aluminum, and phytoestrogens (isoflavones), which may have deleterious 
effects (41).  It is therefore not an ideal choice for the nutritional management of SAM. Elemental 
feeds are very expensive and therefore are not feasible for the management of malnutrition in 
resource-constrained settings. There are other lactose free/low lactose feeds available that may 
be better options to soya or elemental feeds. If lactose malabsorption is commonly found in 
children with SAM and diarrhoea this may indicate the potential benefit of more widespread use 
of more appropriate lactose-free feeds in their management, such as modified cow’s milk based 
lactose free/low lactose feed. 
 
Children who have reducing substances greater than 0.5 g% have been shown, in an observational 
study in 1972, to respond to a diet free of the implicated sugar (demonstrated by stool 
chromatography)  (27). It must be noted that this study was not performed on children with 
malnutrition. Since then no other studies were identified that specifically investigated the 
treatment of children with excessive reducing substances in their stool, who were fed a lactose-
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free or low lactose formula on admission. There are studies, including a meta-analysis of 29 
studies, that have looked at treating children with acute gastroenteritis with low-lactose or 
lactose free formula which have found benefit, especially in those children with significant 
dehydration, malnutrition or persistent diarrhoea  (42-45).  
 
 
2.7 Reason for this study 
Although many studies have investigated children with malnutrition and diarrhoea, few have 
specifically looked at the prevalence of lactose malabsorption in these children. In those studies 
that do report its prevalence, the figures are conflicting. This study aims to determine the 
prevalence of lactose malabsorption in children with SAM and diarrhoea in a current South 
African setting. As a secondary objective, identifying clinical risk factors for the presence of 
lactose malabsorption may help to identify children that could benefit from testing for lactose 
malabsorption. If found to be prevalent, this would warrant a future study to investigate the 
effect of appropriate lactose free feeds in children with SAM and diarrhoea with documented 
lactose malabsorption in a similar setting.    
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3. 0 METHODS  
3.1 Study type 
This Study was a prospective observational study. 
 
3.2 Study sample 
The study participants consisted of a convenience sample of patients admitted to Rahima Moosa 
Mother & Child Hospital, between six months and five years old who were diagnosed with SAM 
(according to current WHO criteria (2)), with or without diarrhoea (defined as 3 or more watery 
stools a day). The samples were collected between 1 December 2012 and 30 November 2013.   
 
3.3 Inclusion criteria 
Children (aged between six months and five years) with SAM, as defined by the presence of one 
or more of the following (2): 
1. Weight-for-height Z-score according to the WHO 2006 growth charts of less than – 3 standard 
deviations. 
2. MUAC < 115mm. 
3. Bilateral pitting oedema at least of the feet, excepting those with other conditions causing 
pitting oedema (e.g. nephrotic syndrome or congestive cardiac failure), regardless of the weight-
for-height Z-score or MUAC.  
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3.4 Exclusion criteria 
Parent or legal guardian declined to provide consent. 
 
3.5 Methods  
1. The participants’ demographic, clinical and laboratory findings, including HIV status were 
noted in the questionnaire (see appendix B) after informed consent (see appendix C) was 
obtained.  This information was often already obtained as it was usually part of the 
routine history and investigation of these patients at the hospital, but it was verified (and 
completed when necessary) with the caregiver for the purposes of the study.  
 
2. A fresh stool sample was taken from the study participant as soon as possible after 
enrolment (when necessary, a small feeding tube was inserted into the anus to a depth of 
1 cm in order to obtain the sample).  Treatment already instituted was noted.  
 
3. The stool sample was immediately tested for the presence of reducing substances, using 
Benedict’s solution. The solution was prepared by the Department of Pharmacy and 
Pharmacology of the University of the Witwatersrand. The reagent contained 100g 
Sodium carbonate, 173g tri-sodium citrate dehydrate, 17.3g copper (II) sulphate 
pentahydrate in 1000mL distilled water. Benedict’s solution was added to an equal 
volume of stool water. The combined solution was heated by submerging the mixture in 
boiling water (boiling point of water in Johannesburg is 91°C) for 15 minutes.  The level of 
reducing substances was then determined by the presence of a colourimetric change.  A 
standardised chart (see appendix A) was used to compare the colour change observed 
with the relevant level of reducing substances in the stool water. The study participant 
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was considered to have lactose malabsorption if the colourimetric change corresponded 
with 0.5% or more reducing substances.  
 
4. The result of the Benedict’s test was communicated to the treating physician for further 
management by them.  
 
3.6 Data analysis 
Data was captured into REDCap electronic data capture tools hosted at The University of the 
Witwatersrand  (46).  Analysis was performed using Stata software (47). Comparisons of 
proportions were done using chi-squared tests with Fisher exact where appropriate. Variables 
were compared using Student’s t-test or Wilcoxon rank test when the data was not normally 
distributed. Risk factors with p-values below 0.2 or those that had been found to be of 
significance in previous studies were included in logistic regression analysis to identify 
independent risk factors. P-values less than 0.05 were considered significant. Anthropometrics 
were analysed using WHO Anthro 2005® software.  
 
 
3.7 Ethical considerations 
The protocol was approved by the Committee for Research in Human Subjects at the University of 
the Witwatersrand (Medical) before data collection commenced.  The study was conducted in line 
with the Declaration of Helsinki principles.  
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 As this is a prospective study, no data collection was done without informed consent from the 
parent or legal guardian. A copy of the participant information sheet and informed consent 
(appendix C) was given to the parent or legal guardian.  The sheet had contact information of the 
researcher and of the Committee for Research in Human Subjects at the University of the 
Witwatersrand from whom ethical clearance was granted (reference: M121045, appendix D). The 
study was completed anonymously.  
 
There was no incentive for participation besides that of gaining information that could help other 
children who may have similar medical conditions to the participant.  
 
The only direct identifiable risk to the participants was one of trauma to the anus caused by 
insertion of the tip of a thin lubricated feeding tube 1 centimetre into the anus.  This was a 
theoretical risk as a literature search did not find any reports of significant trauma caused by stool 
collection using this technique.  There were no incidents of trauma to any of the study 
participants caused by this procedure during the study. The result of the Benedict’s test was 
communicated to the treating clinicians and they could modify treatment of the participant if they 
deemed necessary.  
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3.8 Study Setting 
The study was performed at Rahima Moosa Mother and Child Hospital, a district level hospital in 
Coronationville, that serves a socioeconomically poor urban community in Johannesburg, 
Gauteng. It offers paediatric and maternity services and admits over 3000 paediatric patients 
annually.  There is no specific dietary management protocol for children with SAM and diarrhoea 
and they are managed at the discretion of the treating clinicians. They are mostly commenced on 
a commercial starter formula and the caloric content is increased after the stabilisation phase.  
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4.0 RESULTS 
4.1 Demographics 
 
Figure 4.1: Study participants  
The study participants are described in figure 4.1. All identified, eligible participants consented to 
inclusion in the study. One was excluded for not meeting the anthropometric criteria and one was 
excluded for not meeting the age criteria. The median age was 12 months (range: 6 – 38 months). 
The age of the study population is demonstrated in figure 4.2. The demographics of the sample 
population are described in table 4.1. The housing and amenities of the study population are 
compared to provincial and national data in table 4.2.  
 
81 Participants 
83 Identified 
2 Excluded 
63 with diarrhoea 
18 without diarrhoea 
1 Died  
16 Discharged 
1 Left against 
medical advice  
4 Died 
59 Discharged  
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Figure 4.2 : Age distribution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  33.5%  
  
 15% 
  
  19% 
 12.5% 
7.5% 
  6% 
 2.5% 
 1% 1% 1% 1% 
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Table 4.1: Demographics 
 
Variable Total study 
population 
n (%) 
Sex  
    Male 
 
39 (48) 
    Female 42 (52) 
Housing  
    Brick 
 
41(51) 
    Iron Sheeting 40 (49) 
Water source 
    Indoor tap 
 
42 (52) 
    Communal tap 37 (46) 
    River water 1 (1) 
    Water tank 1 (1) 
Toilet type 
    Flush 
 
57 (70) 
    Pit latrine 19 (24) 
    Bucket system 5 (6) 
Electricity in house 
    Yes 
 
48 (59) 
    No 33 (41) 
Over Crowding 
    Yes 
 
22 (59) 
    No 19 (23) 
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Table 4.2: Housing and amenities of the study population compared to Gauteng and South African 
statistics 
 
* All statistics for Gauteng and South Africa, except for electricity statistics, were sourced from 
The Child Health Gauge 2013  (48).  Electricity statistics were sourced from The Child Health 
Gauge 2007/2008  (49) as they were last included in the annual Child Health Gauge then.  
Definitions used for each parameter in the table are found in appendix E. 
** p value 1 – compares the difference between the study results and Gauteng statistics 
*** p value 2 – compares the difference between the study results and South Africa statistics 
 
 
 
 
 
 
 
 Study Gauteng* South Africa* p value 1 ** p value 2 *** 
Formal 
Housing 
51% 80.6% 74.0% <0.005 <0.005 
Adequate 
Sanitation 
70% 91.6% 69.1% <0.005 0.861 
Adequate 
Water 
52% 93.3% 66.3% <0.005 0.006 
Electricity  59% 93.3% 66.4% <0.005 0.01 
Overcrowding 77% 20.8% 21.0%  <0.005 <0.005 
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4.2 Severe acute malnutrition 
 
Figure 4.3: Parameters of SAM in Study Population 
Figure 4.3 represents the clinical criteria of SAM with which the study population presented. Fifty 
percent of participants presented with only one of the three criteria.  
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4.3 Diarrhoea 
4.3.1 Presence of lactose malabsorption 
Seventy eight percent (63/81) of the study participants had diarrhoea.  Fifty nine percent (37/63) 
of these had reducing substances 0.5% or greater (positive for lactose malabsorption).  A further 
13% (8/63) had reducing substances of 0.3 or 0.4%, which is considered suggestive for lactose 
malabsorption. Twenty nine percent (18/63) had reducing substances of 0.2% or less, which is 
considered negative for lactose malabsorption. For the purpose of discussing predictive factors for 
lactose malabsorption in children with SAM and diarrhoea, only children with reducing sugars 
greater than or equal to 0.5% were considered to have lactose malabsorption. 
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4.3.2 Risk factors for lactose malabsorption  
Table 4.3 Risk factors investigated for their association with the presence of reducing substances 
in stool of children with diarrhoea and SAM 
 Lactose 
Malabsorption 
(Reducing 
Substances 
≥0.5%) 
No lactose 
Malabsorption 
(Reducing 
Substances 
<0.5%) 
Test and Test 
Statistic 
p value 
Age in months 
median (range) 
 9 (6 – 32) 
 
14 (6 – 38) 
 
 Wilcoxon rank test 
 
0.033 
Age <12 months 
 n (%) 
25 (69%) 11(31%)  *OR: 2.84  
95%CI: (1.01 – 7.99) 
*0.046 
Episodes of loose stool in 
past 24 hours n (IQR) 
6  
 (5-8) 
5 
(3-6) 
Wilcoxon rank test 0.038 
Stool frequency >7/24 
hours n (%) 
10 (83%) 2 (17%)  *OR 4.44  
95%CI:  0.96 –
20.56 
*0.054 
Median duration of 
diarrhoea on presentation 
(range) 
3 
 (1- 16) 
6  
(2 – 25) 
 Wilcoxon rank test 0.004 
Duration of diarrhoea >7 
days n (%) 
10 (43%) 13 (57%) *OR: 0.53 
95%CI: 0.15 – 1.80 
*0.301 
Presence of perianal skin 
excoriation n (%) 
15 (71%) 6 (29%)  *OR: 2.38  
95% CI: 0.77-7.32 
 
*0.127 
Fever n (%) 
(temperature >38.0°C) 
11 (55%) 9 (45%)  *OR: 0.799 
95%CI: 0.27-2.35 
*0.682 
Severity of 
dehydration 
n (%) 
  
 
 None 7 (19%) 8 (31%)  
*OR: 1.52          
95%CI: 0.54-4.23 
  
 
*0.423 Mild 12 (32%) 8(31%) 
Moderate 
to severe 
18 (49%) 10 (38%) 
HIV Infected n (%) 9 (14%) 
 
6 (10%)   
 
 
Pearson Chi2: 0.21 
 
 
 
0.901 
HIV Exposed Uninfected n 
(%)   
 
15(24%) 12 (20%) 
HIV Uninfected n (%) 
 
13 (21%) 8 (13%) 
Oedema (%) 16(25%) 7(11%) *OR: 2.07 
95%CI: 0.67-6.11 
*0.185 
* Odds ratio, test statistic Chi Square 
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Potential risk factors that are related to the presence of reducing substances are represented in 
Table 4.3. The data in this table only represents the 63 participants who had diarrhoea. 
 
The duration of diarrhoea on presentation was found to be significantly shorter in the group 
positive for reducing substances. The number of loose stools was found to be marginally, but 
statistically significantly increased in the group that was positive for reducing substances.  Age 
was significantly lower in the group with positive reducing substances. The rest of the risk factors 
were not found to have a significant association with reducing substances. 
Table 4.4: Multivariate analysis of risk factors associated with positive reducing substances 
Variable Category Bivariate Odds 
Ratio (95%CI) 
p Value  Multivariate 
Odds Ratio 
(95%CI) 
p Value 
Age  < 12 months 
(vs ≥ 12 
months)  
2.8 (1.01-8.0) 0.049 
 
3.3   (1.01-10.5) 0.047 
Stool 
Frequency 
> 7 per 24hours  
(vs ≤ 7 per 24 
hours) 
4.4 (0.9-22.3) 0.070 3.7(0.7-20.1) 0.131 
Dehydration Moderate-
Severe  
(vs None – 
Mild) 
1.5 (0.5-4.2) 0.424 1.9 (0.6-5.9) 0.294 
Perianal Skin 
Excoriation 
Present 
(vs Absent) 
2.43 (0.87-7.30) 0.132 2.1    (0.6-7.4) 0.264 
Oedema Present 
(vs Absent) 
2.1 (0.7-6.1) 0.189 2.2 (0.6-10.2) 0.131 
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The factors for the multivariate analysis were chosen because they have been shown to be 
associated with positive reducing substances in stool in previous studies and/or they had a p value 
of <0.2 on univariate analysis. Dehydration was included because it has been shown to be a 
significant feature of osmotic diarrhoea and of lactose malabsorption specifically  (20,50). After 
multivariate analysis, children younger than 12 months were 3.3 times more likely to have 
positive reducing substances than children older than 12 months (95% CI: 1.1 – 10.5, p= 0.047), 
when corrected for stool frequency, dehydration, perianal skin excoriation and oedema.  
4.4 HIV  
Table 4.5: HIV Prevalence   
HIV Status n (%) 
Infected 21 (26%) 
Exposed and uninfected  33 (41%) 
Not exposed and confirmed negative  27 (33%) 
Unknown 0 (0%) 
 
*HIV status was confirmed with an HIV PCR or antibody test (antibody test performed in children 
18 months or older) 
The table includes all the study participants – those with and without diarrhoea. 
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4.5 Participant outcome 
Table 4.6 shows the variables that were investigated for their association with participant 
outcome. Ninety three percent (75/81) of the study participants were discharged home. Six 
percent (5/81) died. One participant’s parents refused further hospital treatment and left the 
hospital against medical advice. The participant who was removed from hospital against medical 
advice was excluded from the study for the purposes of participant outcome calculations.  
The median number of days in hospital for those who were successfully treated with positive 
reducing substances was 10 days (range: 1 – 58).  The median number of days in hospital for those 
who were successfully treated with negative reducing substances was 11 (range 5 – 38, p=0.63 
Wilcoxon rank test).  
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Table 4.6: Variables investigated for their association with participant outcome 
 Death  
n = 5  
Discharged  
n = 75 
Test and Test 
Statistic 
P value 
HIV infected  
n (%) 
0 (0%) 21 (28%) Pearson Chi
2
:  0.210 0.901 
Age <12 months (%) 3 (60%) 42 (56%) *OR:  1.18  
95%CI: 0.18-7.54 
*0.861 
MUAC <115mm  
n (%) 
3 (60%) 31 (41%) *OR: 2.13  
95%CI 0.34-12.18 
*0.424 
WFA Z Score less than – 4 SD  
n (%) 
3 (60%) 29 (39%) *OR: 2.52 
95%CI: 0.41-15.35 
*314 
Oedema 
 n (%)  
2 (40%)  26 (34%)  *OR: 1.26 
95%CI:0.20 – 8.07 
*0.808 
Diarrhoea  
n (%) 
4 (80%) 59 (79%) *OR: 1.08 
95%CI: 0.11-10.54 
*0.943 
 Reducing substances 
≥0.5% n (%) 
4/4(100%) 33/59 (56%) *OR undefined #  *0.035 
Reducing substances 
<0.5% n (%) 
0/4 (0%) 26/59 (44%) 
Anaemia 
(Haemoglobin <10g/dl) 
 n (%) 
 
4 (80%) 
 
35 (47%) *OR: 4.57 
95%CI: 0.57 – 36.45 
*0.149 
Hypoxia  
(Saturations < 89% in room 
air)  
n (%) 
2 (40%) 12 (16%) *OR: 3.5 
95%CI: .057 – 21.32 
*0.712 
Severe hypokalaemia 
(Potassium < 2.5 mmol/L)  
n (%) 
0 (0%) 18 (24%) *OR undefined # *0.104 
Severe Acidosis  
(CO2 <16mmol/L)  
n (%) 
 3 (60%) 42 (75%) * OR: 1.18 
95%CI 0.18 -7.54) 
*0.861 
 
(all variables were measured on admission) 
# OR could not be defined as denominator is 0 
* Odds ratio, test statistic Chi Square 
The median reducing substances of children who were treated successfully was 0.5% (range 0.0 – 
1), while of those who demised, the median reducing substances were 0.55% (range 0.5 – 0.6).  Of 
the 5 participants who died, 4 had diarrhoea, all of whom had lactose malabsorption (stool 
reducing substances of 0.5%, 0.5%, 0.6% and 0.6%). One participant who died had no diarrhoea, 
but had a patent ductus arteriosus, which could have been a significant contributing factor to 
their death. Of the participants with diarrhoea, 4/4 (100%) of those who died had lactose 
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malabsorption and of those who were discharged, 42/75 (56%) had lactose malabsorption. 
Children with SAM and diarrhoea were more likely to die if they had lactose malabsorption  (p= 
0.035). The small number of deaths in the study did not allow for variance within that group.  All 
the participants who died had lactose malabsorption and therefore an odds ratio and logistical 
regression analysis could not be done. There were no other factors that were found to be 
significantly associated with death.  
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5.0 DISCUSSION AND CONCLUSION 
5.1 Demographics  
 
 
The study hospital is a district level hospital that serves a socioeconomically poor urban 
community in Johannesburg, Gauteng, South Africa.  The hospital also serves surrounding 
informal settlements.  The poor socioeconomic circumstances of the study population is reflected 
by the low prevalence of an indoor tap, a flushing toilet and electricity as well as the low 
prevalence of a formal dwelling and a high prevalence of overcrowding. In the annual South 
African Child Gauge, the prevalence of these amenities, housing type and overcrowding, across 
the different provinces of South Africa, including a national average is investigated (among many 
other parameters that impact on child health).  Table 4.2 compares results of our study 
participants with data from the 2013 and 2007/2008 South African Child Gauges.  
 
As represented in the table, there was significantly less formal housing within the study 
population, more overcrowding and less access to basic amenities than the provincial averages. 
Unfortunately, similar figures for the districts served by the hospital are not available. This 
indicates that the participants in this study had poorer than average access to these amenities, 
compared to available provincial and national estimates. Malnutrition is generally more prevalent 
in poorer communities (as indicated by the World Bank estimates on malnutrition (1)) making this 
a relevant setting in which to conduct this study.  
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5.2 Severe acute malnutrition 
Most of the study participants had a weight-for-height Z-score of less than minus three, a third 
had nutritional oedema and almost half had a MUAC of less than 115mm. As demonstrated in 
figure 4.3, half of children with SAM will only present with one of the three WHO criteria (2) and 
in almost half of these, the single defining criteria will be nutritional oedema or a MUAC of less 
than 115mm. It is therefore important to examine for nutritional oedema and measure the MUAC 
when assessing nutritional status, as a large proportion will be missed if only weight-for-height Z-
scores are used. 
 
5.3 Diarrhoea 
5.3.1 Presence of lactose malabsorption 
The Benedict’s test was performed after initial hospital treatment was started (which for none of 
the participants included lactose free feeds, but rather no feeds when the participant was 
severely ill, or lactose containing feeds when more stable). More than half of the study 
participants with diarrhoea had lactose malabsorption.  This is higher than the prevalence of 
lactose malabsorption in children with SAM and diarrhoea found in other studies  (24, 50-52). In 
light of this information and that these children also appear to be at increased risk of mortality 
(see section 5.5), consideration should be given to the routine testing of stool for reducing 
substances in children presenting with SAM and diarrhoea.   
 
The high prevalence of lactose malabsorption demonstrated in this study, supported by the 
previous similar findings should encourage future RCTs comparing F 75 (and other formulas 
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commonly used in the acute management of diarrhoea in children with SAM) with the best 
available alternative, which is believed to be a low osmolality, lactose free milk based formula (38) 
to examine their impact with respect to recovery rates, time to resolution of diarrhoea, weight 
gain and mortality and thereby optimise the management of these high risk children. The existing 
research on nutritional management of children with malnutrition does not include substantial 
research specifically on children with malnutrition and diarrhoea or lactose malabsorption and 
has therefore not been successful in influencing policy change in existing management guidelines 
in these circumstances.   
 
5.3.2 Risk factors for lactose malabsorption 
Both young age and a stool frequency of more than seven per 24 hours were found to be 
associated with lactose malabsorption. Once corrected for other possible associated variables in 
the multivariate analysis, age was the only significant predictive factor for positive reducing 
substances. Young age has previously been found to be associated with lactose malabsorption, 
therefore this finding is in keeping with previous studies (5), however other factors previously 
found to have an association with lactose malabsorption, did not have any predictive value in this 
study. 
 
 The reported duration of diarrhoea was unexpectedly found to be shorter in children with lactose 
malabsorption than in those without. A longer duration of diarrhoea has previously been found to 
be associated with lactose malabsorption (53). This is not of major clinical importance, but 
suggests that lactose malabsorption should be considered regardless of the duration of diarrhoea 
reported. 
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The presence of perianal skin excoriation, severity of dehydration and HIV infection were 
expected to be associated with lactose malabsorption but there was no significant association 
found.  This may be due to small sample size (type II error).  
 
It was expected that fever might be negatively associated with lactose malabsorption, rather 
indicating an infective cause for the diarrhoea (although the two may co-exist).  It however did 
not have a significant association. 
 
5.4 HIV  
HIV prevalence in pregnant mothers, from National HIV Survey 2011  (55), was 29.5% in South 
Africa and 28.7% in Gauteng.  In this study, confined to children with SAM, the prevalence of 
children exposed to HIV was 67%.  In the 2012 South African Child Gauge, the prevalence of HIV in 
children was 2.9% both in Gauteng and South Africa  (56). The prevalence of HIV in this study was 
almost 25%, but was confined to children with SAM.  HIV has previously been found to be more 
prevalent in children with malnutrition than in those without, which is reflected in our results that 
show higher HIV exposure and infection rates than the national and regional averages. A study 
done at the same hospital 5 years prior to this study, also on children with malnutrition 
demonstrated an HIV prevalence of 51%  (57).  The reduction in HIV prevalence, by half, in the 
same group of patients is evidence of effective HIV treatment and prevention, especially, 
improved prevention of mother to child transmission. A systematic review and meta-analysis of 
17 studies (4891children) in Sub-Saharan Africa  (58) found that the prevalence of HIV in children 
with SAM was 29%, similar to our sample.  
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5.5 Participant outcome  
In-hospital mortality rate in the study was close to the 5% mortality rate that WHO claims can be 
achieved by implementation of their guidelines for the treatment of malnutrition, and lower than 
the 20% (and greater) mortality rate seen in many settings in Southern Africa (5). Between 2005 
and 2007, in-hospital mortality rates in South Africa for children under 18 years old, ranged from 
three to 15 deaths per 100 admissions, 40% of these deaths were in children who were classified 
as either marasmic, kwashiorkor or marasmic-kwashiorkor  (58). The latest (2012) in-hospital 
mortality rate for children managed at the study hospital was 1 per 100 admissions in children 
aged 28 days to 1 year. In comparison to these rates, the in-hospital mortality rate in this study 
falls on the lower end of the spectrum of the national data, but the high risk for mortality of 
patients with diarrhoea and SAM is demonstrated by the increased in-hospital mortality rate of 
children in the study as compared to the hospital statistics (p<0.005). 
 
There was no significant difference found in the duration of hospital stay of participants with 
lactose malabsorption compared to those without. At the time of the study, there was no 
standard treatment protocol at RMMCH for the management of children with reducing 
substances found in their stools.  The Benedict’s test result was communicated to the treating 
clinicians and the decision to change to a lactose-free formula depended on their personal 
preference, experience and on the availability of lactose-free formula in the hospital at that 
particular time.  This inconsistency in the treatment of these children could have affected the 
duration of their hospital stay and further studies would need to be done to evaluate the impact 
of treating children with stool positive for reducing substances with lactose-free or low lactose 
formula.  
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Death was more likely in the presence of detected stool reducing substances (p=0.035). This may 
indicate the clinical importance of screening children with SAM and diarrhoea for lactose 
malabsorption.  They could then be identified as being at higher risk for mortality and managed 
accordingly. Although it has already been suggested that all children with malnutrition and 
diarrhoea be managed with feeds that are low in lactose (or lactose free) and have a low 
osmolality (5,8,38), further studies on the appropriate management of children with SAM and 
diarrhoea with positive reducing substances still need to be conducted.  
 
5.6 Limitations 
The parents were asked questions from the questionnaire and this subjected the study to recall 
bias, but this effect should have been uniform across all the study participants.   
 
The Benedict’s test relies on a colourimetric change which is compared to a standardised chart 
(appendix A), the interpretation of the colour is somewhat subjective.  Inter-observer bias was 
minimised by only one researcher conducting the Benedict’s test.   
 
Reducing substances were only tested for once, on or shortly after admission. This was usually 
after initial medical and dietary hospital treatment (including lactose containing feeds) had been 
commenced. The hospital treatment was not thought to affect the result of the Benedict’s test. 
Timing or composition of last meal was not considered.  It is possible that some participants, who 
did not have lactose malabsorption when tested, developed lactose malabsorption during their 
hospital stay.  These patients would not have been identified. 
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The study was conducted in a single hospital over a one year period and the study sample was 
therefore small. This could have resulted in decreased variability in the study results, particularly 
in the group that died (only five participants).   Other associations with lactose malabsorption may 
have been evident in a larger study population, specifically a longer duration of diarrhoea, the 
presence of perianal skin excoriation and dehydration.  
 
5.7 Conclusion 
Malnutrition contributes significantly to the burden of disease in South Africa and globally. 
Diarrhoea is a frequent and serious complication of malnutrition. Lactose malabsorption was 
found to be common in children with SAM and diarrhoea in this study.  Age of less than 12 
months was found to be the only significant factor predicting lactose malabsorption when 
correcting for other variables. The presence of lactose malabsorption was associated with higher 
mortality in children with SAM and diarrhoea. Clinicians treating children with SAM and diarrhoea 
should consider testing stool for reducing substances as those with a positive result could be at 
increased risk for mortality.  While studies have investigated the dietary management of 
malnourished children with diarrhoea, there have been no studies that specifically investigate the 
management of malnourished children who have documented lactose malabsorption. This study 
highlights the need for a future study investigating the impact of the use of the most appropriate 
lactose free feeds on the recovery of children with SAM whose stool is positive for reducing 
substances. 
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Appendix A 
 
Benedict’s test colour chart 
 
(With corresponding level of Reducing Substances) 
 
 
 
 
 
 
 
 
 
  
 
 
 
        
 
0% 0.25% 0.5% 0.75% 1% 2% 
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Appendix B 
Questionnaire  
Study Number: 
Date completed: 
Date of admission: 
Demographics and housing: 
Age:      
Sex Male Female    
Housing type Brick Iron Sheeting Mud Other  
Number of 
Rooms for 
sleeping 
    
 
 
Number of 
people in 
household 
     
Usual water 
source 
Indoor tap Communal 
tap 
River Borehole Other 
Toilet Type None Pit latrine Bucket 
system 
Flush toilet  
Electricity Yes No    
 
SAM Indicators: 
Admission weight:    
Admission 
length/height: 
   
Z Scores: Actual 
measure
ment: 
Z score:  
Weight for age: 
 
   
Height for age: 
 
   
Weight for height: 
 
   
MUAC : 
 
 <115mm >115mm 
Oedema 
(bilateral pitting 
involving at least 
the feet)  
 Present Absent 
Skin fold thickness    
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Diarrhoea: 
Diarrhoea Present Absent  
Consistency Watery Explosive Blood/Mucus 
Duration <14 days >14 days  Date of onset:  
Episodes in a 24 
hour period 
(max) 
    
Vomiting: Present Absent Date of onset:  
Perianal skin 
erosion: 
Present Absent   
 
Feeding: 
Breast 
exclusive 
Formula 
Exclusive  
 
Type of 
formula: 
 
 
Mixed Feeding 
 
 
Type of 
formula: 
 
 
Estimated 
date of 
introduction: 
 
 
 
Complementary Food  
(list details) 
 
 
 
Medical: 
HIV Status Positive Negative Exposed  Not 
exposed 
 
 On ART 
Date of 
initiation: 
 
 
 On NVP   
 Not on ART  Not on NVP   
 Co-
trimoxasole 
Prophylaxis 
 Co-
trimoxasole 
Prophylaxis 
  
 WHO 
Clinical 
Stage:  
    
 CD4 Count: 
CD4 %: 
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Date: 
 
Co morbidity UTI Pneumonia/LRTI TB Meningitis Other: 
 
 
Health care 
before 
current 
admission 
None Clinic Traditional 
Healer 
General 
Practitioner 
Other: 
Previous 
admission  
Yes No Date 
discharged: 
Number of 
admissions 
in the last 
year: 
 
 
Antibiotics Used more 
than 3 
weeks ago 
Used in last 3 
weeks 
Used in last 
2 weeks 
Used in last 
week 
Name of 
Antibiotic 
Antimicrobials 
used during 
this 
admission, 
prior to stool 
collection: 
 
Highest 
Recorded 
Temperature 
     
Dehydration 
on admission  
Mild Moderate Severe  Not 
assessed 
 
Hypoxia 
during 
admission 
Yes No Lowest recorded sats: 
Vaccinations 
Missed: 
 
Rotavirus 
vaccination 
dates: 
 
Final 
Outcome: 
Death Discharged 
Duration of 
stay: 
Absconded 
or refused 
hospital 
treatment 
Transferred: 
 
Name of 
facility:   
 
Referred 
to step 
down 
facility: 
 
Name of 
facility: 
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Investigations: 
Hb  
CRP  
WCC  
Neutrophil %  
Lymphocyte %  
Monocyte %  
Eosinophil %  
Platelets  
Blood Culture  
Total protein  
INR  
PTT  
Sodium  
Potassium  
Urine: Leucocytes  
Urine: Culture (and sensitivity)  
Stool Reducing substance %  
Stool Microscopy  
Stool Culture  
Stool Electron Microscopy  
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Appendix C 
Participant information sheet and informed consent 
Introduction and Invitation to participate: 
Hello.  My name is Britta McLaren, I am a master’s student and I am doing a research project for my degree.  
I would like to ask for some of your time to explain the research that I am doing and to ask for you and your 
child’s help to do this research. Research is the way that we find information that can help us to answer 
certain questions.   
Please feel free to ask any questions during our discussion. 
What is the reason for this study? 
This study is not part of the normal care that your child will receive in hospital, but it is being done to learn 
more information that will help us to treat children like yours. There are many children in South Africa who 
are very underweight for their age (whose weight is much lower than other children their age) and have 
diarrhoea (having watery stools).  The presence of diarrhoea in a child who is very underweight for their age 
can make health of the child worse than if the child did not have diarrhoea. We are trying to identify some 
of the causes of diarrhoea in underweight children, especially lactose intolerance (which is when the body 
does not absorb the sugar found in breast milk, cow’s milk and most formulas) and infections (germs that 
may be causing diarrhoea – this is not for the master’s research, but for other research). Only children 
under the age of 5 who are admitted at this hospital are invited to participate in this study 
What is involved in the study? 
Should you decide to join the study, I would like to ask you a few questions( face-to-face, in a private 
space), about your child’s past and present health, previous medicines used and vaccines received, HIV 
status and living conditions.  I would need to assess your child’s weight, height, measure around the upper 
part of their arm and I would like your permission to have a look at your child’s hospital file and blood test 
results (and to record this information).  I would then need to take a little bit of your child’s stool (poo).  The 
stool sample will be taken from your child’s nappy or bed pan. If this is not possible, a small, soft tube will 
be inserted into your child’s bottom and some stool will be sucked out.  This is not a painful procedure and 
you are welcome to watch while it is being done.  I have done this many times before and have never 
caused any harm when doing it. It is the normal way that doctors take a sample of stool if they need one 
and they can’t get it from the nappy.  
 I will tell you the results of the testing for sugar in the stool immediately, but the testing for germs takes a 
few days to weeks. If you want to know these results I can arrange that.  If it is found that your child does 
not actually fit the definition of malnutrition (very underweight for age) that I am using then I will no longer 
need you to participate in this study. 
Expected duration of participation: 
In total I will take about 30 minutes of your time.  If your child does not pass any stool before I am finished, I 
may need to come back later in the day to collect the stool sample.  
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What are the risks of this study? 
I do not for see any risks to you or your child should you decide to participate in the study. The tube that we 
use to suck out some stool is thin and will cause very little pain or discomfort. It is a procedure that has 
been done many times and there are no likely complications from this procedure. If anything unexpected 
does occur as a result of this procedure, I will take the responsibility of making sure that it is fixed as best as 
possible.  
What will be benefits of this study? 
Your child will not directly benefit from the study, but if I do gain any information from the stool testing, 
that I think will help your doctors to treat your child better, I will (with your permission) tell them the 
information. Your child’s treatment however will not change if you agree or don’t agree to participate in the 
study, your doctors will still offer you the same services. The information that we collect may be used to 
help other children who have a similar condition to your child. You may ask me any questions, which may 
help you to understand your child’s condition better and I am available to discuss any concerns that you 
have about your child if you wish.  
What are your rights in this study? 
It is your right to give permission for me to include your child in the study or not. If you choose to 
participate, you may change your mind at any stage or choose not to answer any question(s). If you choose 
not to participate or decide to leave the study once you have agreed to be a part of it, your child will 
continue to receive treatment and will not lose out on any health services.  
Confidentiality of participant information: 
I will make every effort to keep all your information confidential and anonymous.  Absolute confidentiality 
cannot be guaranteed.  Personal information may be disclosed if required by law. Organizations that may 
inspect and/or copy research records for quality assurance and data analysis include groups such as the 
Research Ethics Committee but all your information will be put under a study number and not your name. 
None of the study personnel or the people who access this study will know which information (including 
HIV status) belongs to you or your child. 
What are the costs? 
There will be no cost involved for you if you choose for your child to participate in the study. You will also 
not receive any payment for taking part. 
Contact details: 
If you have any questions about the study, your child’s rights within the study or any concerns that you 
have to do with the study, you may contact me at any time: 
Dr Britta McLaren:  0114709127/0832256282. 
 This study has received ethical approval from the Human Research Ethics committee of the University of 
the Witwatersrand (M121045), Johannesburg (011 7171234). If you have any questions about the rights of 
you or your child as a participant in this study or the ethics of this study, please contact the office on the 
above number. 
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Informed Consent for Participation: 
Parent or legal guardian declaration section: 
I, ___________________________________ (name of parent/guardian), agree that the nature of 
the study questions, examination and stool collection have all been explained to me and that I 
agree that my child may participate in the following study procedures: 
I agree to be interviewed and allow information from my child’s hospital records and 
laboratory results (including the HIV status) to be collected for this study.  
I agree for my child’s weight, height and mid upper arm circumference to be 
measured 
I agree to the testing of my child’s stool for the presence of germs and lactose 
intolerance 
 
 
 
Yes 
 
 
 
 
No 
 
 
The signature of the parent or legal guardian below means that the study has been explained to 
them and that they understand what it entails and agrees that that their child may participate. 
 
Name of parent or legal guardian: 
 
Signature of parent or legal guardian: 
 
Date: 
 
Name of witness: 
 
Signature of witness: 
 
Date: 
 
 
 
Name of researcher:  
Signature of researcher:  
Date:  
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Storage of samples for future testing: 
Patient information section: 
Once your child’s stool sample has been tested for the purpose of this study, the sample may be stored 
anonymously, for an indefinite period of time in a general bank in the laboratory for testing in the future. 
This is a normal procedure that is done in the laboratory.  It is done so that if new germs are discovered in 
the future, the laboratory can look back at old samples to see if they can find the germ in older samples 
which would show that the ‘new germ’ was actually always there, but they didn’t know how to find it in the 
old samples.  If the germ is not found in old samples, then they will know that this germ is really a new germ 
that has developed.  The samples in the bank are also used when new tests are developed, to verify the 
new tests by testing old samples with the new test.  No genetic testing (testing for your child’s DNA or 
genes) will ever be done. 
You may give permission for the laboratory to store the sample or not.  
Parent or legal guardian declaration section: 
I, ___________________________________ (name of parent/guardian), agree that the nature 
and purpose of stool storage for future testing has been explained to me. 
I agree for my child’s stool sample to be stored for possible testing the future  Yes No 
The signature of the parent or legal guardian below means that the storage of the stool sample 
has been explained to them and that they understand what it entails and agrees that that their 
child’s stool sample may be stored for future testing. 
 
Name of parent or legal guardian: 
 
Signature of parent or legal guardian: 
 
Date: 
 
Name of witness: 
 
Signature of witness: 
 
Date: 
 
 
Name of researcher:  
Signature of researcher:  
Date:  
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Appendix D  
Ethical clearance certificate 
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Appendix E 
Definitions 
 
1 Formal housing: a dwelling or brick structure on a separate stand, flat or apartment, 
town/cluster/semi-detached house, unit in retirement village, room or flatlet on a larger property. 
‘Informal’ housing: The following housing types: informal dwelling or shack in backyard, informal 
dwelling or shack in informal settlement, dwelling or house/flat/room in backyard, caravan or tent 
(45).   
 
2 Adequate toilet facilities (used as proxy for basic sanitation): Includes facilities that are safe, 
reduce odours and are within or near a house. Inadequate sanitation includes a wide range of 
poor toilet facilities including pit latrines that are not ventilated, chemical toilets, buckets, or no 
facilities at all(45). 
 
3 Adequate drinking water: Access to a clean and reliable water supply that is at their house. All 
other water supplies, including rivers and communal taps, are considered inadequate (45). 
 
4 Electricity: Households that have an electricity connection include households that are 
connected to the mains electricity supply (46). 
 
5 Overcrowding: a ratio of more than two people per room (excluding bathrooms but including 
kitchen and living room). There is no standard measure of overcrowding in South Africa, but there 
are many international definitions. The definition used here is derived from the United Nations 
Human Settlement Program (UN-HABITAT) definition, which is a maximum of two people per 
habitable room. ‘Habitable’ excludes bathroom and toilet (45). 
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Appendix F 
Plagiarism Report 
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